ES8404852A1 - Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos - Google Patents

Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos

Info

Publication number
ES8404852A1
ES8404852A1 ES525441A ES525441A ES8404852A1 ES 8404852 A1 ES8404852 A1 ES 8404852A1 ES 525441 A ES525441 A ES 525441A ES 525441 A ES525441 A ES 525441A ES 8404852 A1 ES8404852 A1 ES 8404852A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
isoquinoline derivatives
isoquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES525441A
Other languages
English (en)
Spanish (es)
Other versions
ES525441A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES525441A0 publication Critical patent/ES525441A0/es
Publication of ES8404852A1 publication Critical patent/ES8404852A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES525441A 1982-09-09 1983-09-07 Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos Expired ES8404852A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823233424 DE3233424A1 (de) 1982-09-09 1982-09-09 Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung

Publications (2)

Publication Number Publication Date
ES525441A0 ES525441A0 (es) 1984-05-16
ES8404852A1 true ES8404852A1 (es) 1984-05-16

Family

ID=6172780

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525441A Expired ES8404852A1 (es) 1982-09-09 1983-09-07 Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos

Country Status (19)

Country Link
US (1) US4673682A (forum.php)
EP (1) EP0105210B1 (forum.php)
JP (1) JPS5967270A (forum.php)
KR (1) KR840006206A (forum.php)
AT (1) ATE25679T1 (forum.php)
AU (1) AU1891683A (forum.php)
CA (1) CA1211445A (forum.php)
DE (2) DE3233424A1 (forum.php)
DK (1) DK408083A (forum.php)
ES (1) ES8404852A1 (forum.php)
FI (1) FI833200A7 (forum.php)
GR (1) GR79382B (forum.php)
HU (1) HU191094B (forum.php)
IL (1) IL69683A0 (forum.php)
NO (1) NO833217L (forum.php)
NZ (1) NZ205513A (forum.php)
PH (1) PH18186A (forum.php)
PT (1) PT77309B (forum.php)
ZA (1) ZA836663B (forum.php)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956371A (en) * 1989-09-19 1990-09-11 Euroceltique, S.A. Substituted isoquinolines and methods of using same
ES2152938T3 (es) * 1992-09-28 2001-02-16 Hoechst Ag 1(2h)-isoquinolinas sustituidas antiarritmicas y cardioprotectoras, procedimiento para su produccion, medicamento que las contiene y su uso para la produccion de un medicamento para combatir fallos cardiacos.
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
NZ543448A (en) * 2003-06-06 2009-02-28 Fibrogen Inc Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin
CN103382216B (zh) * 2006-01-27 2016-04-20 菲布罗根有限公司 使低氧诱导因子(hif)稳定的氰基异喹啉化合物
US7696223B2 (en) * 2006-04-04 2010-04-13 Fibrogen, Inc. Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereof
US8927591B2 (en) 2008-11-14 2015-01-06 Fibrogen, Inc. Thiochromene derivatives as HIF hydroxylase inhibitors
AU2013229922B2 (en) 2012-03-09 2017-09-28 Fibrogen, Inc. 4 -hydroxy- isoquinoline compounds as HIF hydroxylase inhibitors
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
KR20210130849A (ko) 2012-07-16 2021-11-01 피브로겐, 인크. 프롤릴 하이드록실라제 억제제 [(4-하이드록시-1-메틸-7-페녹시-아이소퀴놀린-3-카보닐)-아미노]-아세트산의 결정형
US9340511B2 (en) 2012-07-16 2016-05-17 Fibrogen, Inc. Process for making isoquinoline compounds
WO2014116849A1 (en) 2013-01-24 2014-07-31 Fibrogen, Inc. Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2054482B1 (forum.php) * 1969-07-11 1973-06-08 Anvar
FR2424270A1 (fr) * 1978-04-24 1979-11-23 Rhone Poulenc Ind Nouveaux derives de l'isoquinoleine, leur preparation et les compositions qui les contiennent
DE2818423A1 (de) * 1978-04-27 1979-11-08 Hoechst Ag Neue isochinolinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0105210A3 (en) 1984-10-10
KR840006206A (ko) 1984-11-22
IL69683A0 (en) 1983-12-30
ATE25679T1 (de) 1987-03-15
AU1891683A (en) 1984-03-15
DE3369983D1 (en) 1987-04-09
FI833200A7 (fi) 1984-03-10
PT77309B (de) 1986-04-18
FI833200A0 (fi) 1983-09-07
DK408083D0 (da) 1983-09-08
ES525441A0 (es) 1984-05-16
JPS5967270A (ja) 1984-04-16
ZA836663B (en) 1984-04-25
CA1211445A (en) 1986-09-16
PT77309A (de) 1983-10-01
HU191094B (en) 1987-01-28
DK408083A (da) 1984-03-10
DE3233424A1 (de) 1984-03-15
GR79382B (forum.php) 1984-10-22
NZ205513A (en) 1986-05-09
US4673682A (en) 1987-06-16
NO833217L (no) 1984-03-12
EP0105210A2 (de) 1984-04-11
EP0105210B1 (de) 1987-03-04
PH18186A (en) 1985-04-12

Similar Documents

Publication Publication Date Title
EP0500143A3 (en) Pharmaceutical composition comprising an aminoglycoside phosphate
ZA926328B (en) Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them.
IL69095A (en) 9-(2-hydroxyethoxymethyl)-guanine derivatives,their preparation and pharmaceutical compositions containing them
IL57648A (en) 2-substituted-5,9-dimethyl-2'-hydroxy-6,7-benzomorphanes,their preparation and pharmaceutical compositions containing them
ES8801277A1 (es) Procedimiento para preparar (1,2,4) triazolo (1,5-c) quinazolinas
IL96636A0 (en) Piperidine derivatives and pharmaceutical compositions containing them
ES8402261A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega difenil-aza-alcano.
DE3167320D1 (en) Novel uracil derivatives, process for preparing the same and a pharmaceutical composition containing the same
ES8102561A1 (es) Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles
ES8207124A1 (es) Un procedimiento para la preparacion de derivados de aminas secundarias.
IL108571A0 (en) Derivatives of quinolonecarboxylic acid and naphthyrdionecarboxylic acid, their preparation and pharmaceutical compositions containing them
ES8403494A1 (es) "un procedimiento para la preparacion de derivados de s-adenosilmetionina".
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
ES8403910A1 (es) Procedimiento para la preparacion de nitratos de amino-deso-xi-1.4;3.6-dianhidro-hexito,asi como de sus sales de adicionacida farmacologicamente inocuas
ES8401944A1 (es) Procedimiento para la preparacion de derivados de acido salicilico.
TW252979B (forum.php)
ES8801633A1 (es) Procedimiento para preparar nuevos derivados de 3-piridil-metilnaftilo
GR3033993T3 (en) N-benzylpiperazinderivatives, process for their preparation and pharmaceutical compositions containing them.
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
ES8201575A1 (es) Procedimiento de obtencion de nuevos 2-aminoetanoles
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
ATE23528T1 (de) +/- 2-((3,4-methylenedioxy)phenethyl)-5-((3carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidine, pharmazeutische zusammenstellungen die sie enthalten, verfahren zur herstellung und deren zwischenprodukte.
ZA948515B (en) Cyclised analogues of fatty acid metabolites,a process for their preparation and pharmaceutical compositions containing them